MicrobeWorld App

appsquarebannerad200x200

ASM Fellowships

Fellowship

Microbes After Hours

WaterSupplyYouTubeFrame

Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email

subscribe

Featured Image

Featured Video

Ebola Virus explained

Supporters

ASM House 200X200

Updates: Whatever Happened to the Universal Flu Vaccine?

A goal in fighting influenza is a universal vaccine, one that works on many strains of the pathogen [see “Beating the Flu in a Single Shot”; Scientific American, June 2008]. But the virus’s outer coat, consisting mainly of proteins called hemagglutinin and neuraminidase, frequently mutate, forcing the reformulation of vaccines every season. Two studies report the discovery of human antibodies that target an area on hemagglutinin that does not change much. (In contrast, current drugs, such as Tamiflu, aim for neuraminidase.) In tests, one of the antibodies protected mice from lethal doses of avian flu (H5N1) and other strains. Large amounts were needed, however, so any human treatment could be expensive. The papers were published in the March Nature Structural and Molecular Biology and online February 26 by Science Express.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use